이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
IVD Medical Holding 관리
관리 기준 확인 2/4
IVD Medical Holding's CEO는 Kuk Sing Ho, Jun2019 에 임명되었습니다 의 임기는 8.08 년입니다. 총 연간 보상은 CN¥ 3.70M, 99.8% 로 구성됩니다. 99.8% 급여 및 0.2% 보너스(회사 주식 및 옵션 포함). 는 HK$ 154.46M 가치에 해당하는 회사 주식의 12.96% 직접 소유합니다. 154.46M. 경영진과 이사회의 평균 재임 기간은 각각 5 년과 2.7 년입니다.
주요 정보
Kuk Sing Ho
최고 경영자
CN¥3.7m
총 보상
| CEO 급여 비율 | 99.8% |
| CEO 임기 | 5.1yrs |
| CEO 소유권 | 13.0% |
| 경영진 평균 재임 기간 | 5.1yrs |
| 이사회 평균 재임 기간 | 2.8yrs |
최근 관리 업데이트
Recent updates
Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2023 | CN¥4m | CN¥4m | CN¥238m |
| Sep 30 2023 | n/a | n/a | CN¥235m |
| Jun 30 2023 | n/a | n/a | CN¥232m |
| Mar 31 2023 | n/a | n/a | CN¥221m |
| Dec 31 2022 | CN¥5m | CN¥4m | CN¥210m |
| Sep 30 2022 | n/a | n/a | CN¥193m |
| Jun 30 2022 | n/a | n/a | CN¥177m |
| Mar 31 2022 | n/a | n/a | CN¥176m |
| Dec 31 2021 | CN¥4m | CN¥4m | CN¥175m |
보상 대 시장: Kuk Sing 의 총 보상 ($USD 509.64K )은 Hong Kong 시장( $USD 351.75K ).
보상과 수익: Kuk Sing 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Kuk Sing Ho (64 yo)
5.1yrs
테뉴어
CN¥3,700,000
보상
Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 5.1yrs | CN¥3.70m | 12.96% CN¥ 138.7m | |
| GM & Executive Director | 5.1yrs | CN¥2.16m | 8.32% CN¥ 89.0m | |
| CFO, Joint Company Secretary & Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Financial Controller | 8.4yrs | 데이터 없음 | 데이터 없음 | |
| Company Secretary | no data | 데이터 없음 | 데이터 없음 |
5.1yrs
평균 재임 기간
47yo
평균 연령
경험이 풍부한 관리: 1931 의 관리팀은 노련하고 경험 (평균 재직 기간 5 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 8.2yrs | CN¥3.70m | 12.96% CN¥ 138.7m | |
| GM & Executive Director | 8.5yrs | CN¥2.16m | 8.32% CN¥ 89.0m | |
| CFO, Joint Company Secretary & Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 5.1yrs | CN¥120.00k | 데이터 없음 | |
| Independent Non-Executive Director | 5.1yrs | CN¥120.00k | 데이터 없음 | |
| Non-Executive Director | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Non-executive Director | less than a year | 데이터 없음 | 데이터 없음 |
2.8yrs
평균 재임 기간
51yo
평균 연령
경험이 풍부한 이사회: 1931 의 이사회는 경험(평균 재직 기간 2.7 년)으로 간주되지 않으므로 새 이사회가 필요합니다.